EBME 426. Gene and Drug Delivery
Description
Compared with traditional therapeutics, new therapeutics require comprehensive understandings of modern biology (e.g., molecular biology and genetics), physiology, biomaterials, and engineering. Gene and drug delivery by a controlled release holds hope and promise in treatment of challenging diseases (e.g., cancer, Alzheimer, HIV, and cardiovascular diseases). Obstacles to gene and drug delivery becoming a conventional treatment in clinics and current status of the technology will be introduced and extensively discussed. Finally, synergistic combinations of this technology with other areas of biomedical engineering (e.g., imaging and stem cell engineering) will also be introduced.
Course Goals
An objective of this course is to provide graduate or high level senior students with comprehensive and updated knowledge in gene and drug delivery systems. Students will learn basic theories and principles of gene and drug delivery. The course will clarify importance of multidisciplinary approaches to gene and drug delivery technology. This course places an emphasis on reading review and research articles throughout the lecture. Therefore, students will acquire basic and intermediate knowledge in the gene/drug delivery area, critical paper reading skills, and developing/presenting their own ideas. Through case studies, clinical potentials and impacts of gene and drug delivery technology will also be demonstrated.
Prerequisites
EBME 316 or equivalent, or approval of instructor.
Class Format
Lecture.
Typical Class Size
10-30
Semesters and Years Offered
Offered spring semester every year.
Computer Usage
The students need to know how to use Matlab and Microsoft
Word for assignments and PowerPoint for presentation.
Engineering Concentration or Biomedical Sciences Course?
This course counts for ½ engineering concentration and ½ biomedical sciences course.
|
